Nice hypothesis. Two issues.
Firstly, Wolgen has been as emphatic as humanly possible that with him in charge afamelanotide WILL NEVER be used for a cosmetic tan.
Secondly, Clinuvel over the last 5 years have reinterpreted the under promise over deliver mantra to under promise and then even with incredibly low expectations fail to meet them and set a new standard in under delivery.
How’s that vitiligo trial going? Wouldn’t mind an update.
Nice hypothesis. Two issues. Firstly, Wolgen has been as...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.37 |
Change
0.180(1.36%) |
Mkt cap ! $669.5M | |||
| Open | High | Low | Value | Volume |
| $13.19 | $13.59 | $13.13 | $1.181M | 88.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 606 | $13.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.51 | 282 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |